Specialty Overview

Best Hospitals for Head and Neck Cancer Treatment in India

90 surgical oncology hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the surgical oncology hospitals in our directory offering Head and Neck Cancer Treatment in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Documented costs range from $1,800 to $9,000 depending on the exact diagnosis, based on our published cost guides.

Ask us about head and neck cancer treatment in India

Share a few details and our care coordination team will get back to you with next steps.

Compare 90 accredited hospitals for Surgical Oncology in India

Starting from$1,000

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Apollo Hospitals
Starting from$1,000

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity
Starting from$1,000

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital
Starting from$1,000

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute
Starting from$1,000

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Kokilaben Dhirubhai Ambani Hospital
Starting from$1,000

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital
Starting from$1,000

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering head and neck cancer treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Max Super Specialty Hospital
Starting from$1,000

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Narayana Health
Starting from$1,000

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviewsAccredited by NABH1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
Accredited by NABH

Patients considering head and neck cancer treatment can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Yashoda Hospitals, Hi-Tech City
Starting from$1,000

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviewsAccredited by JCI, NABH2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
Accredited by JCI, NABH

Patients considering head and neck cancer treatment can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing head and neck cancer treatment.

4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Head and Neck Cancer Treatment in India?

Choosing the right hospital for head and neck cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Head and Neck Cancer Treatment

Head and neck cancer treatment encompasses a multidisciplinary spectrum of surgical resections, precision radiotherapy, immunotherapy, and targeted molecular therapies directed at malignancies arising in the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, salivary glands, and thyroid.

7–21 days (varies by modality: 7–10 days for major surgical resection; 3–5 days for concurrent chemoradiation induction; up to 3 weeks for complex reconstructive cases)
Hospital Stay
4–8 weeks (surgical and reconstructive cases require 6–8 weeks; definitive chemoradiation patients typically cleared for international travel at 4–6 weeks post-treatment completion, subject to oncologist sign-off)
Total Stay in Country (Fit-to-Fly)
50–90%+ (stage- and subsite-dependent; early-stage laryngeal and HPV-positive oropharyngeal cancers exceed 85–90% five-year survival; locally advanced disease 40–60% with multimodal therapy)
Success Rate

Clinical Overview

  • Head and neck cancers are a heterogeneous group of malignancies, the vast majority (>90%) being squamous cell carcinomas (HNSCC), arising from the mucosal epithelium lining the upper aerodigestive tract.
  • Primary subsites include the oral cavity (lips, tongue, floor of mouth, buccal mucosa), oropharynx (base of tongue, tonsils, soft palate — increasingly driven by high-risk HPV-16 infection), larynx (supraglottic, glottic, subglottic), hypopharynx, nasopharynx, and major and minor salivary glands.
  • Thyroid malignancies — papillary, follicular, medullary, and anaplastic — are categorized separately but managed within head and neck oncology programs.
Full details →

Who is a Candidate?

  • ELIGIBLE CANDIDATES:
  • Newly diagnosed head and neck squamous cell carcinoma (HNSCC) of any subsite, confirmed by endoscopic biopsy with histopathological analysis including HPV/p16 status (via IHC and/or PCR), EBV serology (nasopharyngeal), and PD-L1 Combined Positive Score (CPS)
  • Patients with differentiated thyroid cancer (papillary or follicular) of any risk category, or medullary thyroid cancer with germline RET mutation analysis
  • Locally advanced disease (Stage III–IVB) being evaluated for organ-preservation concurrent chemoradiation vs. primary surgical resection with reconstruction
  • +23 more

Treatment Options & Approaches

  • SURGICAL APPROACHES:

Recovery

  • PHASE 1 — PRE-TREATMENT EVALUATION (Days 1–14 before treatment start):

Risks to be aware of

  • Head and neck cancer treatment carries a specific and substantial risk profile that patients must understand before committing to therapy.
  • Surgical risks include free-flap failure (partial or total — occurring in 3–8% of cases even at expert centers), requiring urgent return to the operating room; fistula formation (orocutaneous or pharyngocutaneous) particularly in previously irradiated fields or malnourished patients; wound infection and dehiscence; injury to the facial nerve (VII), hypoglossal nerve (XII), accessory nerve (XI — causing shoulder dysfunction), or recurrent laryngeal nerve (RLN — permanent voice change or aspiration); and carotid artery injury in the setting of radical neck dissection for fixed nodal disease.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive, seamlessly coordinated end-to-end logistics for international patients traveling to India or the UAE for head and neck cancer treatment, removing all administrative and non-clinical burdens so patients can focus entirely on recovery.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about Head and Neck Cancer Treatment

What is the cost of head and neck cancer treatment in India vs. the UAE?
The cost of head and neck cancer treatment varies considerably based on disease stage, subsite, and the specific treatment protocol — whether that involves surgery alone, definitive chemoradiation, combined multimodal therapy with reconstruction, or immunotherapy with agents such as pembrolizumab. In India, at JCI- and NABH-accredited oncology centers in cities such as Mumbai, Delhi, Chennai, and Bengaluru, the total treatment cost typically ranges from $4,000 to $35,000 USD. A straightforward early-stage surgical procedure (e.g., transoral robotic surgery for T1 oropharyngeal cancer plus selective neck dissection, with 5–7 days of hospitalization) falls in the $4,000–$10,000 range. A complex case requiring total laryngectomy, bilateral neck dissection, and pectoralis major myocutaneous flap reconstruction with 14–21 days of inpatient care may reach $15,000–$25,000. Full-course concurrent chemoradiation (35 fractions of IMRT + 6–7 weekly cisplatin cycles + supportive care over 7 weeks) runs approximately $8,000–$18,000. Immunotherapy with pembrolizumab, if required for recurrent/metastatic disease, adds $3,000–$7,000 per cycle and is typically not included in surgery-based package estimates. In the UAE, at JCI- and DHA-accredited institutions in Dubai (such as Mediclinic City Hospital, American Hospital Dubai, King's College Hospital Dubai) and Abu Dhabi (Cleveland Clinic Abu Dhabi, Sheikh Shakhbout Medical City), comparable treatment costs range from $10,000 to $75,000 USD. The significant premium reflects higher facility costs, physician fees structured on Western benchmarks, luxury private room standards, and the overall cost of operating in a high-income economy. An equivalent transoral robotic surgery case may cost $12,000–$22,000 in Dubai; a full course of chemoradiation runs $20,000–$40,000; and complex surgical reconstruction with extended hospitalization can reach $50,000–$75,000. In summary, India is consistently 40–60% less expensive than the UAE for equivalent oncology procedures, making it the most cost-efficient destination globally for head and neck cancer treatment without compromise in clinical outcomes. GAF Healthcare provides a no-obligation, itemized cost estimate for your specific diagnosis and treatment plan within 48 hours of receiving your medical reports.
How long do I need to stay in the country before I am fit to fly home after head and neck cancer treatment?
The minimum safe in-country stay before international air travel — what oncologists refer to as 'fit-to-fly' clearance — depends critically on which treatment modality you undergo, and is always determined on an individual basis by your treating team. For patients undergoing SURGICAL TREATMENT (e.g., transoral robotic surgery, open resection with neck dissection, or major ablative surgery with free-flap microvascular reconstruction): Simple transoral surgical cases with minimal reconstruction typically require 3–4 weeks in-country before flying (approximately 2–3 weeks post-operatively, allowing wound healing confirmation and swallowing rehabilitation initiation). Complex cases involving total laryngectomy, fibular free-flap mandibular reconstruction, or pharyngeal reconstruction require a minimum of 6–8 weeks in-country. This extended stay ensures: complete wound healing and absence of fistula; successful tracheotomy decannulation (where applicable); establishment of safe oral or enteral feeding; removal of all drains and sutures; and post-operative histopathology review to finalize the adjuvant therapy plan. Patients with tracheostomies (permanent stomas post-total laryngectomy) may fly when stoma care is self-sufficient and cabin pressure concerns have been reviewed — typically after 6–8 weeks. For patients undergoing DEFINITIVE CONCURRENT CHEMORADIATION (7 weeks of daily IMRT + weekly cisplatin): Treatment itself lasts approximately 7 weeks (35 fractions). Following the last radiation fraction, patients are generally advised to remain in-country for a further 3–5 weeks — a total in-country stay of approximately 10–12 weeks. This post-radiation period is necessary for: resolution of Grade 3 oral mucositis (typically heals within 4–6 weeks post-radiation completion); nutritional rehabilitation and removal of nasogastric tube or PEG; renal function and hematological recovery post-cisplatin; the 12-week PET-CT response assessment (per NI-RADS guidelines), which determines whether a planned neck dissection is required; and oncologist confirmation that you are medically stable for travel. For patients receiving IMMUNOTHERAPY (pembrolizumab): If ongoing IV immunotherapy cycles are required (administered every 3 weeks), these can frequently be continued at a partnered oncology center in your home country after GAF Healthcare facilitates medical records transfer and treatment handover. Fitness to fly between cycles is generally achievable 7–10 days after each infusion if no significant immune-related adverse events (irAEs) have occurred. As a general planning benchmark, international patients and their families should budget for a total in-country stay of 4–6 weeks (surgical cases, minimal reconstruction) to 12–14 weeks (combined chemoradiation with response assessment). GAF Healthcare's medical coordinators work directly with your treating oncologist to issue a formal fit-to-fly certificate with specific recommendations regarding cabin pressure, oxygen supplementation, deep-vein thrombosis prophylaxis, and travel medications before you depart.
What is the success rate of head and neck cancer treatment?
The success rate of head and neck cancer treatment — most meaningfully expressed as five-year overall survival (OS) — is highly variable and depends on four key factors: anatomical subsite of the primary tumor, clinical stage at diagnosis (per AJCC 8th Edition TNM), HPV/p16 status (for oropharyngeal cancers), and the volume and expertise of the treating institution. Here is a clinically realistic breakdown by subsite and stage: OROPHARYNGEAL CANCER (HPV-positive, p16+): This is now the most favorable subtype. Five-year OS for Stage I–II HPV-positive oropharyngeal cancer exceeds 85–90%. Even Stage III disease achieves 70–80% five-year OS with concurrent chemoradiation. HPV-positive disease has a fundamentally better prognosis than HPV-negative HNSCC due to superior radiosensitivity, which is why AJCC 8th Edition introduced a separate, less aggressive staging system for this subtype. De-escalation trials (OPTIMA, ECOG-ACRIN 3311, MC1273) are actively investigating reduced-intensity CRT to preserve these excellent outcomes while reducing long-term toxicity. ORAL CAVITY CANCER: Five-year OS ranges from approximately 80–90% for Stage I, 60–75% for Stage II, 40–55% for Stage III, and 20–35% for Stage IVA disease. Negative surgical margins and absence of extranodal extension (ENE) are the strongest predictors of cure. LARYNGEAL CANCER: Early-stage (T1 glottic) laryngeal cancer — often treated with transoral laser microsurgery or radiotherapy — has a five-year local control and disease-specific survival rate exceeding 90–95%. T2 disease achieves 70–80% five-year OS. Locally advanced (T3–T4) laryngeal cancer treated with organ-preservation CRT achieves 50–65% five-year OS, with laryngeal preservation in approximately 70–80% of those who survive. NASOPHARYNGEAL CANCER: Highly radiosensitive, nasopharyngeal carcinoma treated with definitive CRT (cisplatin + IMRT ± induction/adjuvant chemotherapy) achieves five-year OS rates of 80–90% for Stage I–II and 60–70% for Stage III–IVA, reflecting the effectiveness of platinum-based CRT in this EBV-driven malignancy. THYROID CANCER: Papillary thyroid cancer — the most common thyroid malignancy — has a ten-year disease-specific survival exceeding 98% for low-risk disease (ATA low-risk category). Even high-risk differentiated thyroid cancer achieves five-year OS of 60–80% with total thyroidectomy, radioiodine ablation, and TSH suppression. Medullary thyroid cancer has a five-year OS of approximately 70–90% for localized disease. Anaplastic thyroid cancer remains the most aggressive solid tumor in oncology, with median OS of 5–6 months even with multimodal therapy, though BRAF V600E-mutant cases respond to dabrafenib+trametinib with dramatically improved outcomes. RECURRENT/METASTATIC HNSCC: First-line pembrolizumab (for PD-L1 CPS ≥1, KEYNOTE-048) achieves a median OS of 13 months as monotherapy and up to 13.6 months in combination with chemotherapy — a meaningful improvement over the historic 10.1-month median OS with the EXTREME cetuximab-based regimen. At GAF Healthcare's partner institutions — all high-volume JCI- or NABH/DHA-accredited head and neck oncology programs — free-flap reconstruction success rates exceed 95%, TORS negative margin rates are comparable to international benchmarks (>85% R0 resection), and IMRT planning adheres to QUANTEC and RTOG dose constraint guidelines. Institutional volume is one of the strongest independent predictors of survival in head and neck oncology, and our partner hospitals perform hundreds of head and neck cancer procedures annually.
The Cost Landscape

Surgical Oncology Treatment Cost in India, by Diagnosis

Use the cost calculator

From our published, verified cost guides only — each row links through to the full breakdown.

DiagnosisRange, USD
Breast Cancer$1,800–$9,000View breakdown →

Indicative planning estimates only, not a quote — actual pricing depends on your case, hospital choice, and length of stay.

How GAF Healthcare Assists in Choosing the Best Hospital for Head and Neck Cancer Treatment in India

Discover the Top Hospitals for Head and Neck Cancer Treatment in India

This page lists 90 accredited surgical oncology hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about head and neck cancer treatment in India

How many surgical oncology hospitals are listed in India?
90 hospitals in our India directory are currently listed for surgical oncology including Head and Neck Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
Which cities in India have surgical oncology hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for head and neck cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
🤔

Still have questions?

Our coordinators are here to answer your questions about head and neck cancer treatment in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for head and neck cancer treatment in India.

Contact us to report an inaccuracy on this page.